Methylglyoxal and advanced glycation end products in patients with diabetes: what we know so far and the missing links

Hyperglycemia explains the development of late diabetic complications in patients with diabetes type 1 and type 2 only partially. Most therapeutic efforts relying on intensive glucose control failed to decrease the absolute risk for complications by more than 10%, especially in patients with diabete...

Full description

Saved in:
Bibliographic Details
Main Authors: Gröner, Jan (Author) , Oikonomou, Dimitrios (Author) , Cheko, Ruan (Author) , Kender, Zoltán (Author) , Zemva, Johanna (Author) , Kihm, Lars Philipp (Author) , Muckenthaler, Martina (Author) , Peters, Verena (Author) , Fleming, Thomas (Author) , Kopf, Stefan (Author) , Nawroth, Peter Paul (Author)
Format: Article (Journal)
Language:English
Published: 2019
In: Experimental and clinical endocrinology & diabetes
Year: 2019, Volume: 127, Issue: 8, Pages: 497-504
ISSN:1439-3646
DOI:10.1055/s-0043-106443
Online Access:Verlag, Volltext: http://dx.doi.org/10.1055/s-0043-106443
Verlag, Volltext: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-106443
Get full text
Author Notes:Jan Benedikt Groener, Dimitrios Oikonomou, Ruan Cheko, Zoltan Kender, Johanna Zemva, Lars Kihm, Martina Muckenthaler, Verena Peters, Thomas Fleming, Stefan Kopf, Peter P. Nawroth

MARC

LEADER 00000caa a2200000 c 4500
001 1575559390
003 DE-627
005 20250327125733.0
007 cr uuu---uuuuu
008 180528s2019 xx |||||o 00| ||eng c
024 7 |a 10.1055/s-0043-106443  |2 doi 
035 |a (DE-627)1575559390 
035 |a (DE-576)505559390 
035 |a (DE-599)BSZ505559390 
035 |a (OCoLC)1341010104 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gröner, Jan  |e VerfasserIn  |0 (DE-588)1017332444  |0 (DE-627)676373771  |0 (DE-576)353490172  |4 aut 
245 1 0 |a Methylglyoxal and advanced glycation end products in patients with diabetes  |b what we know so far and the missing links  |c Jan Benedikt Groener, Dimitrios Oikonomou, Ruan Cheko, Zoltan Kender, Johanna Zemva, Lars Kihm, Martina Muckenthaler, Verena Peters, Thomas Fleming, Stefan Kopf, Peter P. Nawroth 
264 1 |c 2019 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.05.2018 
500 |a 13. April 2017 (eFirst) 
520 |a Hyperglycemia explains the development of late diabetic complications in patients with diabetes type 1 and type 2 only partially. Most therapeutic efforts relying on intensive glucose control failed to decrease the absolute risk for complications by more than 10%, especially in patients with diabetes type 2. Therefore, alternative pathophysiological pathways have to be examined, in order to develop more individualized treatment options for patients with diabetes in the future. One such pathway might be the metabolism of dicarbonyls, among them methylglyoxal and the accumulation of advanced glycation end products. Here we review currently available epidemiological data on dicarbonyls and AGEs in association with human diabetes type 1 and type 2. 
700 1 |a Oikonomou, Dimitrios  |d 1979-  |e VerfasserIn  |0 (DE-588)1019621168  |0 (DE-627)685503844  |0 (DE-576)358465540  |4 aut 
700 1 |a Cheko, Ruan  |d 1986-  |e VerfasserIn  |0 (DE-588)1151475173  |0 (DE-627)1011829371  |0 (DE-576)497815028  |4 aut 
700 1 |a Kender, Zoltán  |e VerfasserIn  |0 (DE-588)1160213321  |0 (DE-627)1023345080  |0 (DE-576)505561492  |4 aut 
700 1 |a Zemva, Johanna  |d 1986-  |e VerfasserIn  |0 (DE-588)1067679324  |0 (DE-627)819077364  |0 (DE-576)426841433  |4 aut 
700 1 |a Kihm, Lars Philipp  |d 1978-  |e VerfasserIn  |0 (DE-588)131796550  |0 (DE-627)514262087  |0 (DE-576)298757346  |4 aut 
700 1 |a Muckenthaler, Martina  |e VerfasserIn  |0 (DE-588)1046124595  |0 (DE-627)775766496  |0 (DE-576)173146813  |4 aut 
700 1 |a Peters, Verena  |d 1968-  |e VerfasserIn  |0 (DE-588)118132202  |0 (DE-627)69469892X  |0 (DE-576)291731848  |4 aut 
700 1 |a Fleming, Thomas  |d 1982-  |e VerfasserIn  |0 (DE-588)1034445294  |0 (DE-627)745607365  |0 (DE-576)382066804  |4 aut 
700 1 |a Kopf, Stefan  |d 1978-  |e VerfasserIn  |0 (DE-588)1013047516  |0 (DE-627)663343453  |0 (DE-576)346399025  |4 aut 
700 1 |a Nawroth, Peter Paul  |d 1954-  |e VerfasserIn  |0 (DE-588)1020504897  |0 (DE-627)69123941X  |0 (DE-576)360517692  |4 aut 
773 0 8 |i Enthalten in  |t Experimental and clinical endocrinology & diabetes  |d Stuttgart [u.a.] : Thieme, 1995  |g 127(2019), 8, Seite 497-504  |h Online-Ressource  |w (DE-627)32557362X  |w (DE-600)2037702-2  |w (DE-576)273833472  |x 1439-3646  |7 nnas  |a Methylglyoxal and advanced glycation end products in patients with diabetes what we know so far and the missing links 
773 1 8 |g volume:127  |g year:2019  |g number:8  |g pages:497-504  |g extent:8  |a Methylglyoxal and advanced glycation end products in patients with diabetes what we know so far and the missing links 
856 4 0 |u http://dx.doi.org/10.1055/s-0043-106443  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-106443  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180528 
993 |a Article 
994 |a 2019 
998 |g 1020504897  |a Nawroth, Peter Paul  |m 1020504897:Nawroth, Peter Paul  |d 910000  |d 910100  |e 910000PN1020504897  |e 910100PN1020504897  |k 0/910000/  |k 1/910000/910100/  |p 11  |y j 
998 |g 1013047516  |a Kopf, Stefan  |m 1013047516:Kopf, Stefan  |d 910000  |d 910100  |e 910000PK1013047516  |e 910100PK1013047516  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 1034445294  |a Fleming, Thomas  |m 1034445294:Fleming, Thomas  |d 910000  |d 910100  |e 910000PF1034445294  |e 910100PF1034445294  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 118132202  |a Peters, Verena  |m 118132202:Peters, Verena  |d 910000  |d 910500  |e 910000PP118132202  |e 910500PP118132202  |k 0/910000/  |k 1/910000/910500/  |p 8 
998 |g 1046124595  |a Muckenthaler, Martina  |m 1046124595:Muckenthaler, Martina  |d 910000  |d 910500  |d 700000  |d 718000  |e 910000PM1046124595  |e 910500PM1046124595  |e 700000PM1046124595  |e 718000PM1046124595  |k 0/910000/  |k 1/910000/910500/  |k 0/700000/  |k 1/700000/718000/  |p 7 
998 |g 131796550  |a Kihm, Lars Philipp  |m 131796550:Kihm, Lars Philipp  |d 910000  |d 910100  |e 910000PK131796550  |e 910100PK131796550  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1067679324  |a Zemva, Johanna  |m 1067679324:Zemva, Johanna  |d 910000  |d 910100  |e 910000PZ1067679324  |e 910100PZ1067679324  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1160213321  |a Kender, Zoltán  |m 1160213321:Kender, Zoltán  |d 910000  |d 910100  |e 910000PK1160213321  |e 910100PK1160213321  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1019621168  |a Oikonomou, Dimitrios  |m 1019621168:Oikonomou, Dimitrios  |d 910000  |d 910100  |e 910000PO1019621168  |e 910100PO1019621168  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1017332444  |a Gröner, Jan  |m 1017332444:Gröner, Jan  |d 910000  |d 910100  |e 910000PG1017332444  |e 910100PG1017332444  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1575559390  |e 3010327714 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 28.05.2018","13. April 2017 (eFirst)"],"name":{"displayForm":["Jan Benedikt Groener, Dimitrios Oikonomou, Ruan Cheko, Zoltan Kender, Johanna Zemva, Lars Kihm, Martina Muckenthaler, Verena Peters, Thomas Fleming, Stefan Kopf, Peter P. Nawroth"]},"language":["eng"],"title":[{"title_sort":"Methylglyoxal and advanced glycation end products in patients with diabetes","title":"Methylglyoxal and advanced glycation end products in patients with diabetes","subtitle":"what we know so far and the missing links"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"disp":"Methylglyoxal and advanced glycation end products in patients with diabetes what we know so far and the missing linksExperimental and clinical endocrinology & diabetes","part":{"year":"2019","extent":"8","issue":"8","text":"127(2019), 8, Seite 497-504","pages":"497-504","volume":"127"},"pubHistory":["103.1995 -"],"corporate":[{"display":"Deutsche Gesellschaft für Endokrinologie","role":"isb"},{"display":"Deutsche Diabetes Gesellschaft","role":"isb"}],"titleAlt":[{"title":"ECED"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"32557362X","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Experimental and clinical endocrinology & diabetes","title":"Experimental and clinical endocrinology & diabetes"}],"note":["Gesehen am 07.05.24"],"name":{"displayForm":["Deutsche Gesellschaft für Endokrinologie ; Deutsche Diabetesgesellschaft"]},"origin":[{"dateIssuedKey":"1995","dateIssuedDisp":"1995-","publisherPlace":"Stuttgart [u.a.]","publisher":"Thieme"}],"id":{"eki":["32557362X"],"zdb":["2037702-2"],"issn":["1439-3646"],"doi":["10.1055/s-00000017"]}}],"person":[{"given":"Jan","display":"Gröner, Jan","family":"Gröner","role":"aut"},{"given":"Dimitrios","role":"aut","family":"Oikonomou","display":"Oikonomou, Dimitrios"},{"given":"Ruan","role":"aut","family":"Cheko","display":"Cheko, Ruan"},{"given":"Zoltán","role":"aut","display":"Kender, Zoltán","family":"Kender"},{"role":"aut","family":"Zemva","display":"Zemva, Johanna","given":"Johanna"},{"given":"Lars Philipp","family":"Kihm","display":"Kihm, Lars Philipp","role":"aut"},{"display":"Muckenthaler, Martina","family":"Muckenthaler","role":"aut","given":"Martina"},{"role":"aut","family":"Peters","display":"Peters, Verena","given":"Verena"},{"given":"Thomas","display":"Fleming, Thomas","family":"Fleming","role":"aut"},{"given":"Stefan","role":"aut","family":"Kopf","display":"Kopf, Stefan"},{"given":"Peter Paul","role":"aut","display":"Nawroth, Peter Paul","family":"Nawroth"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"id":{"doi":["10.1055/s-0043-106443"],"eki":["1575559390"]},"recId":"1575559390"} 
SRT |a GROENERJANMETHYLGLYO2019